Literature DB >> 14616743

Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance.

E Torell1, I Kühn, B Olsson-Liljequist, S Haeggman, B-M Hoffman, C Lindahl, L G Burman.   

Abstract

OBJECTIVE: To investigate clonal relationships in a nationwide sample of human Enterococcus faecium isolates.
METHODS: Biochemical fingerprinting (PhP (PhenePlate) typing) was used to compare 180 fecal ampicillin-resistant E. faecium (ARE) isolates with 169 matched fecal ampicillin-susceptible E. faecium (ASE) isolates from patients in 23 hospitals, collected in 1998, and to study 39 fecal ARE isolates from non-hospitalized individuals collected in 1998, and five ARE and 29 ASE isolates from the early 1990s. Representative ARE and ASE isolates were subjected to pulsed-field gel electrophoresis (PFGE) analysis of genomic DNA and sequencing of the regions encoding the fluoroquinolone targets of the enzymes GyrA and ParC.
RESULTS: Both PhP and PFGE results showed a higher homogeneity among ARE than among ASE isolates (P < 0.001). One PhP type (FMSE1) comprised 73% of the hospital ARE isolates (53% of ARE isolates from non-hospitalized individuals, and four of five ARE isolates from the early 1990s), but only 1% of the ASE isolates. PFGE of the hospital E. faecium isolates revealed that 23 of the 25 ARE isolates and one of the 22 ASE isolates were of one dominating type. High-level resistance to ciprofloxacin (MIC > 16 mg/L) was present in 91% of ARE isolates, whereas only low-level resistance (MIC 4-16 mg/L; 35% of isolates) was found among ASE isolates. One mutation in parC (codon 80) and one of two mutations in gyrA (codons 83 or 87) were detected in all ARE isolates tested with high-level ciprofloxacin resistance, but were lacking in ARE and ASE isolates with low-level ciprofloxacin resistance.
CONCLUSION: Most ARE isolates in Sweden were clonally related. High-level ciprofloxacin resistance was found in ARE isolates of PhP type FMSE1 as well as in other PhP types, but never in ASE isolates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616743     DOI: 10.1046/j.1469-0691.2003.00701.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions.

Authors:  Inger Kühn; Aina Iversen; Maria Finn; Christina Greko; Lars G Burman; Anicet R Blanch; Xavier Vilanova; Albert Manero; Huw Taylor; Jonathan Caplin; Lucas Domínguez; Inmaculada A Herrero; Miguel A Moreno; Roland Möllby
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  Epidemiological link between wastewater and human vancomycin-resistant Enterococcus faecium isolates.

Authors:  Malihe Talebi; Fateh Rahimi; Mohammad Katouli; Roland Möllby; Mohammad R Pourshafie
Journal:  Curr Microbiol       Date:  2008-02-22       Impact factor: 2.188

3.  Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance?

Authors:  Teresa M Coque; Rob J L Willems; Jesús Fortún; Janetta Top; Sergio Diz; Elena Loza; Rafael Cantón; Fernando Baquero
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium.

Authors:  Helen L Leavis; Rob J L Willems; Janetta Top; Marc J M Bonten
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.